Tag: IBIO

Blue Horseshoe Stocks: RUSS Recap, Gap-Up List & More

Direxion Daily Russia Bear 3X ETF (RUSS)
–
A few weeks back, on February 23rd, we radared the RUSS, which is a fund that trades with an inverse relationship with the Russian economy.

The past week has been particularly troubling for Russia, as its central bank slashed the primary interest rate by a full percent while revealing that its growth forecast predicted a shrinking of the economy by as much as 4% this year.

These and other economic curve-balls, including the continued lag in oil prices, have fueled a healthy rebound in the RUSS from the recent low we observed at 11.22. Friday’s high of 15.77 marked a 40% swing in a matter of eight trading sessions.

With some holding the belief that an even more severe and protracted economic meltdown could be in the cards for Russia, we’ll want to monitor RUSS on an ongoing basis.

Morning Gapper Watchlist

These are a few stocks that are cropping up on our scanner this morning as they gap up in the premarket. We’ll be on the lookout for the possibilities of continued momentum and/or dip-and-rip scenarios:

Microvision, Inc. MVIS  has been in blue-sky breakout mode for the past several sessions, and is gapping up today on the heel of the following PR:

Midstates Petroleum Co. Inc. MPO  is trading up in early activity this morning on a Q4 earnings and revenue beat:
Odyssey Marine Exploration, Inc. OMEX  is also up considerably, following Friday’s news of its entry into a financing agreement to facilitate offshore mineral and resource exploration.The company also has an earnings conference call slated for 10AM today, to discuss the contents of this morning’s filings:

Extended Watchlist:
IBIO, CERS, ACRX, ITEK, CTIC

Blue Horseshoe Stocks: Options Review & More

Last Week’s Options Ideas

Heading into the end of last week we had already been on fire with our options calls in prior sessions, and the exciting trend of huge gain opportunities continued on Friday as well. We floated a couple of last minute daytrading ideas in the web security sector with the following plays, and were handsomely rewarded for our efforts:

CyberArk Software, Ltd. CYBR – With CYBR, we were especially interested in the $50 and $55 Calls. The trading range on the $50’s was from 3.30-5.90. and that registered as an intraday gain of 72% The $55’s saw an even larger move from a low of  .85 on up to 2.25, for chances at gains in excess of 165%

FireEye, Inc. FEYE – For FEYE, we targeted the $39.50, $40, and $40.50 Calls, and once again saw our ideas go green across the board. The $39.50 Calls made a move from 1.28-2.96, increasing 131% intraday. The $40’s made a big leap as well, logging a 220% move up from .75-2.40. Finally, traders in the $40.50 Calls had the opportunity for a double-bagger also, with those contracts rising from a low of .59, and reaching their peak at 1.82, a 208% gain.

Gevo, Inc. GEVO & Lucas Energy, Inc. LEI

These two stocks were two standouts from Friday’s extended watchlist. Both plays offered notable intraday moves, and each of them is gapping up even further this morning.

GEVO traded in a range from .201-.24 for an intraday gain of 19%, and this morning’s premarket high of .28 updates that increase to 39%

LEI performed quite well on Friday also, recording an intraday move from .26 to .362 (+39%). Rising as high as .399 in premarket trading today reflects a total gain of 53% that we’ve seen from Friday’s low.

Earnings Beats to Watch

As most of you are aware we’ve had tremendous good fortune this earnings season using exceeded expectations as leverage in some incredible options trades. We’ve got another pair of potential targets this morning which just beat Wall St. estimates:

VASCO Data Security International, Inc. VDSI – Another play in the presently-popular data security industry, our interest in VDSI is currently in the 03/20 $25 Calls (Closed at 5.06 on Friday) We suspect that they will open significantly higher given VDSI’s gapping up in today’s premarket trading.

Medtronic plc MDT – Concerning MDT, we’re going to keep an eye on the 03/20 $77.50 and $80 Calls. That gives us just under a month before expiration, qualifying both of these options ideas as longer-term items.

Extended Watchlist:
IBIO, ONCY, SGNL, BIOC, MNGA

Blue Horseshoe Stocks: MDCN Refocus & More

Pervasip Corp. PVSP

To kick off this short week we’d like to take note of PVSP, a super-subpenny stock that has recently awoken from the dead and begun to show some vigorous swings on the chart. PVSP has been bouncing around in a rough channel between .0002 and .0004 for the past couple of weeks.

Every so often we like to watch super-subpennies like this one for the low-risk-high-reward factor; with little room to fall, the rock bottom prices represent a true ground-floor opportunity. Many times in the past have we caught on with a play in this situation and reaped the benefit of rapid and monstrous upswings. We’ll keep a close eye on PVSP for the possible chance to do it again.

Last week the company announced that it had completed deal that will allow it to write approximately $2M off of its existing debt for an up-front sum of just $100K, and a later payment of $25K in October. >>> VIEW PR 

Medican Enterprises, Inc. MDCN

MDCN is a marijuana-related stock that we’ve had on our long term radar for quite some time. Toward the beginning of the year we re-tagged the stock for monitoring and today seems like a good time to focus in more intently on a couple of key points that seem to indicate a possible opportunity ahead.

In addition to a recent property acquisition with potentially exciting implications (PR excerpt below), we’re catching MDCN off of its 52-week low which was just realized on Thursday. Our regular readers are well aware of how fond we are of stocks coming up off of their annual lows. We’ve successfully navigated countless plays in this exact situation, and in many cases have come up with major gains for our efforts.

LAS VEGAS–(BUSINESS WIRE)–Medican Enterprises Inc. (MDCN), a company seeking promising pharmaceutical and other business opportunities in the emerging medical and recreational marijuana sector, announced that it has entered into a purchase agreement to acquire a 7,200 square foot retail and commercial property in Phoenix, Arizona.

The property is currently leased through August 2018 to an Arizona state licensed medical marijuana dispensary. Per the purchase agreement, the lease agreement will be assigned to Medican. >> FULL PR

Extended Watchlist:
CYTR, ISR, AUY, EHTH, SWHC, FRO, IBIO